Additionally, a case study reported the successful treatment of an 11-year-old T-ALL patient, who had not responded to initial treatment, with autologous anti-CD7 CAR-T cell therapy resulting in remission by day 17 and subsequent hematopoietic stem cell transplantation (HSCT) (42). Here, CD7 is linked to acute lymphoblastic leukemia.